3 January 2017 - Warning by European Medicines Agency reinforces logistical concerns about Brexit.
The head of the EU’s London-based drugs regulator said the agency had lost an unprecedented number of senior staff since the Brexit vote and warned that as many as half could walk out unless its future is handled properly.
For Guido Rasi, executive director of the EMA, its probable relocation once Britain leaves the EU poses a unique challenge but is also a stark reminder of the broader administrative and logistical quagmire that is likely to follow Brexit.